Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden · Delayed Price · Currency is SEK 2.670
+0.015 (0.56%)
Nov 2, 2026, 5:29 PM CET
Elicera Therapeutics AB Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Elicera Therapeutics AB stock has an average price target of kr 7.25. The average 1-year stock price forecast is 171.54% higher than the current stock price, while the lowest is kr 6.50 (+143.45%) and the highest is kr 8.00 (+199.63%).
Price Target: kr 7.25 (+171.54%)
Analyst Consensus: n/a
Price Target
ChartAnalyst Ratings
There are currently no analyst ratings available for Elicera Therapeutics AB.
Recommendation Trends
No data available
| Rating | Nov 2026 |
|---|---|
| Strong Buy | n/a |
| Buy | n/a |
| Hold | n/a |
| Sell | n/a |
| Strong Sell | n/a |
| Total | n/a |
Financial Forecast
Revenue This Year
1.50M
from 10.86M
Decreased by -86.18%
Revenue Next Year
29.97M
from 1.50M
Increased by 1,897.78%
EPS This Year
-0.42
from -0.38
EPS Next Year
-0.46
from -0.42
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.